Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

The PS-b-PAA copolymer nanomicelles are effective for delivering a cancer treatment drug in photodynamic therapy.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Scalp cooling effectively reduces hair loss from chemotherapy.

EPC-K is stable except at very acidic pH or when exposed to sunlight, and it can decompose in low ethanol concentrations.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Scientists made two new chemicals that might help treat diseases caused by male hormones.

FA2H is essential for normal fur and sebum production in mice.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

A method was created in 2005 to identify minoxidil, a hair growth ingredient, in products using two types of capillary zone electrophoresis, and it found that most products had about 2% minoxidil.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

CSLD1 suppresses rice root hair growth with NH4+ and regulates AMT1;2 expression.

Athletes need effective management of skin disorders for their performance and well-being.

The Wnt/β-catenin pathway can activate melanocyte stem cells and may help regenerate hair follicles.

Newly made nicotinamide compounds could potentially treat cancer.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Cyproterone acetate reduced hair growth in most hirsute females and made hair softer, thinner, and lighter.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.